Page last updated: 2024-09-03

4-iodoamphetamine and Alzheimer Disease

4-iodoamphetamine has been researched along with Alzheimer Disease in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19902 (40.00)18.7374
1990's3 (60.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brandt, J; Burns, A; Folstein, MF; Frost, JJ; Harris, G; Mayberg, H; Sapp, J; Steele, C; Tune, L; Wagner, HN1
Besson, JA; Best, PV; Crawford, JR; Ebmeier, KP; Gemmell, HG; Parker, DM; Sharp, PF; Smith, FW1
Heironimus, JD; Timmons, JH1
Cohen, MB; Graham, LS; Yamada, LS1
Collier, BD; Goldstein, MD; Harsch, HH; Hellman, RS; Tikofsky, RS1

Reviews

1 review(s) available for 4-iodoamphetamine and Alzheimer Disease

ArticleYear
[123I]iodoamphetamine SPECT imaging.
    International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes, 1986, Volume: 37, Issue:8

    Topics: Alzheimer Disease; Amphetamines; Animals; Cerebrovascular Disorders; Dementia; Epilepsy; Humans; Iodine Radioisotopes; Tomography, Emission-Computed

1986

Trials

1 trial(s) available for 4-iodoamphetamine and Alzheimer Disease

ArticleYear
Physostigmine in Alzheimer's disease: effects on cognitive functioning, cerebral glucose metabolism analyzed by positron emission tomography and cerebral blood flow analyzed by single photon emission tomography.
    Acta psychiatrica Scandinavica. Supplementum, 1991, Volume: 366

    Topics: Aged; Alzheimer Disease; Amphetamines; Blood Glucose; Brain; Cerebrovascular Circulation; Deoxyglucose; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuropsychological Tests; Physostigmine; Pilot Projects; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon

1991

Other Studies

3 other study(ies) available for 4-iodoamphetamine and Alzheimer Disease

ArticleYear
Multimodal imaging in Alzheimer's disease. The relationship between MRI, SPECT, cognitive and pathological changes.
    The British journal of psychiatry : the journal of mental science, 1990, Volume: 157

    Topics: Aged; Alzheimer Disease; Amphetamines; Blood Flow Velocity; Brain; Cerebral Arteries; Cerebral Cortex; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Organotechnetium Compounds; Oximes; Psychometrics; Regional Blood Flow; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon

1990
Coexistence of Alzheimer's disease and multi-infarct dementia diagnosed by functional brain imaging with SPECT.
    Clinical nuclear medicine, 1990, Volume: 15, Issue:4

    Topics: Alzheimer Disease; Amphetamines; Dementia, Multi-Infarct; Humans; Tomography, Emission-Computed, Single-Photon

1990
CT, magnetic resonance imaging, and SPECT iodine-123 iodoamphetamine imaging of a patient with progressive cognitive deterioration.
    Clinical nuclear medicine, 1987, Volume: 12, Issue:6

    Topics: Aged; Alzheimer Disease; Amphetamines; Brain; Female; Humans; Iodine Radioisotopes; Magnetic Resonance Spectroscopy; Tomography, Emission-Computed; Tomography, X-Ray Computed

1987